DFTX

Definium Therapeutics is a drug development company working on treatments for brain and mental health conditions. Their main experimental drug, DT120, is being tested in patients with anxiety and depression. They are also developing DT402, derived from MDMA, as a potential treatment for autism spectrum disorder. The company is still in the testing phase and has not yet brought any drugs to market.